ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $0 |
| Operating income | −$155M |
| Net income | −$133M |
| EPS | −$8.64 |
| Free cash flow | −$101M |
Oruka Therapeutics, Inc.
$84.52+1.10 (+1.32%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $0 |
| Operating income | −$155M |
| Net income | −$133M |
| EPS | −$8.64 |
| Free cash flow | −$101M |